Hamostaseologie
DOI: 10.1055/a-2215-9003
Review Article

Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence

1   Department of Cardiology, University Hospital Besançon, Besançon, France
2   SINERGIES, University of Franche-Comté, Besançon, France
3   F-CRIN, INNOVTE network, France
,
Raquel Morillo
4   Respiratory Department, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
5   CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
6   Medicine Department, Universidad de Alcalá, (IRYCIS) Madrid, Spain
,
Nicolas Meneveau
1   Department of Cardiology, University Hospital Besançon, Besançon, France
2   SINERGIES, University of Franche-Comté, Besançon, France
3   F-CRIN, INNOVTE network, France
,
David Jiménez
4   Respiratory Department, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
5   CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
6   Medicine Department, Universidad de Alcalá, (IRYCIS) Madrid, Spain
› Institutsangaben
Funding None.

Abstract

High-risk pulmonary embolism (PE) refers to a large embolic burden causing right ventricular failure and hemodynamic instability. It accounts for approximately 5% of all cases of PE but contributes significantly to overall PE mortality. Systemic thrombolysis is the first-line revascularization therapy in high-risk PE. Surgical embolectomy or catheter-directed therapy is recommended in patients with an absolute contraindication to systemic thrombolysis. Extracorporeal membrane oxygenation (ECMO) provides respiratory and hemodynamic support for the most critically ill PE patients with refractory cardiogenic shock or cardiac arrest. The complex management of these individuals requires urgent yet coordinated multidisciplinary care. In light of existing evidence regarding the utility of ECMO in the management of high-risk PE patients, a number of possible indications for ECMO utilization have been suggested in the literature. Specifically, in patients with refractory cardiac arrest, resuscitated cardiac arrest, or refractory shock, including in cases of failed thrombolysis, venoarterial ECMO (VA-ECMO) should be considered, either as a bridge to percutaneous or surgical embolectomy or as a bridge to recovery after surgical embolectomy. We review here the current evidence on the use of ECMO as part of the management strategy for the highest-risk presentations of PE and summarize the latest data in this indication.



Publikationsverlauf

Eingereicht: 30. Mai 2023

Angenommen: 22. November 2023

Artikel online veröffentlicht:
26. März 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Office of the Surgeon General (US). National Heart Lung, and Blood Institute (US); The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville, MD:: Office of the Surgeon General (US);; 2008
  • 2 White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003; 90 (03) 446-455
  • 3 Cohen AT, Agnelli G, Anderson FA. et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98 (04) 756-764
  • 4 Donaldson GA, Williams C, Scannell JG, Shaw RS. A reappraisal of the application of the Trendelenburg operation to massive fatal embolism. Report of a successful pulmonary-artery thrombectomy using a cardiopulmonary bypass. N Engl J Med 1963; 268: 171-174
  • 5 Conget F, Otero R, Jiménez D. et al. Short-term clinical outcome after acute symptomatic pulmonary embolism. Thromb Haemost 2008; 100 (05) 937-942
  • 6 Sánchez D, De Miguel J, Sam A. et al. The effects of cause of death classification on prognostic assessment of patients with pulmonary embolism. J Thromb Haemost 2011; 9 (11) 2201-2207
  • 7 Konstantinides S, Geibel A, Olschewski M. et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 1997; 96 (03) 882-888
  • 8 Laporte S, Mismetti P, Décousus H. et al; RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117 (13) 1711-1716
  • 9 PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263 (20) 2753-2759
  • 10 Pollack CV, Schreiber D, Goldhaber SZ. et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol 2011; 57 (06) 700-706
  • 11 Lobo JL, Alonso S, Arenas J. et al; En nombre del Panel Multidisciplinar para el Manejo de la TEP. Multidisciplinary consensus for the management of pulmonary thromboembolism. Arch Bronconeumol 2022; 58 (03) 246-254
  • 12 Stevens SM, Woller SC, Baumann Kreuziger L. et al. Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest 2021; 160 (06) 2247-2259
  • 13 Konstantinides SV, Torbicki A, Agnelli G. et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35 (43) 3033-3069 , 3069a–3069k
  • 14 Jiménez D, Rodríguez C, León F. et al; IPEP investigators. Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism. Eur Respir J 2022; 59 (02) 2100412
  • 15 Barbero E, Bikdeli B, Chiluiza D. et al. Performance of early prognostic assessment independently predicts the outcomes in patients with acute pulmonary embolism. Thromb Haemost 2018; 118 (04) 798-800
  • 16 Jiménez D, de Miguel-Díez J, Guijarro R. et al; RIETE Investigators. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. J Am Coll Cardiol 2016; 67 (02) 162-170
  • 17 van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 2014; 124 (12) 1968-1975
  • 18 Meyer G, Vicaut E, Danays T. et al; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370 (15) 1402-1411
  • 19 Jiménez D, Bikdeli B, Barrios D. et al; RIETE investigators. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. Int J Cardiol 2018; 269: 327-333
  • 20 Kucher N, Goldhaber SZ. Risk stratification of acute pulmonary embolism. Semin Thromb Hemost 2006; 32 (08) 838-847
  • 21 Coon WW, Willis PW. Deep venous thrombosis and pulmonary embolism: prediction, prevention and treatment. Am J Cardiol 1959; 4: 611-621
  • 22 Soloff LA, Rodman T. Acute pulmonary embolism. II. Clinical. Am Heart J 1967; 74 (06) 829-847
  • 23 Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17 (04) 259-270
  • 24 Kasper W, Konstantinides S, Geibel A. et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30 (05) 1165-1171
  • 25 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162) 1386-1389
  • 26 Bahloul M, Chaari A, Kallel H. et al. Pulmonary embolism in intensive care unit: predictive factors, clinical manifestations and outcome. Ann Thorac Med 2010; 5 (02) 97-103
  • 27 Piazza G. Advanced management of intermediate- and high-risk pulmonary embolism: JACC focus seminar. J Am Coll Cardiol 2020; 76 (18) 2117-2127
  • 28 Jerjes-Sanchez C, Ramírez-Rivera A, Arriaga-Nava R. et al; de Lourdes García M. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 1995; 2 (03) 227-229
  • 29 Marti C, John G, Konstantinides S. et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015; 36 (10) 605-614
  • 30 Giri J, Sista AK, Weinberg I. et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation 2019; 140 (20) e774-e801
  • 31 Delmas C, Aissaoui N, Meneveau N. et al. Reperfusion therapies in pulmonary embolism-state of the art and expert opinion: a position paper from the “Unité de Soins Intensifs de Cardiologie” group of the French Society of Cardiology. Arch Cardiovasc Dis 2020; 113 (11) 749-759
  • 32 Meneveau N, Séronde MF, Blonde MC. et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest 2006; 129 (04) 1043-1050
  • 33 Azari A, Bigdelu L, Moravvej Z. Surgical embolectomy in the management of massive and sub-massive pulmonary embolism: the results of 30 consecutive ill patients. ARYA Atheroscler 2015; 11 (03) 208-213
  • 34 Goldberg JB, Giri J, Kobayashi T. et al. Surgical management and mechanical circulatory support in high-risk pulmonary embolisms: historical context, current status, and future directions: a scientific statement from the American Heart Association. Circulation 2023; 147 (09) e628-e647
  • 35 Aymard T, Kadner A, Widmer A. et al. Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy: should surgical indications be revisited?. Eur J Cardiothorac Surg 2013; 43 (01) 90-94 , discussion 94
  • 36 Osho AA, Dudzinski DM. Interventional therapies for acute pulmonary embolism. Surg Clin North Am 2022; 102 (03) 429-447
  • 37 Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 1997; 78 (03) 1063-1068
  • 38 Piazza G, Hohlfelder B, Jaff MR. et al; SEATTLE II Investigators. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv 2015; 8 (10) 1382-1392
  • 39 Tapson VF, Sterling K, Jones N. et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial. JACC Cardiovasc Interv 2018; 11 (14) 1401-1410
  • 40 Piazza G, Sterling KM, Tapson VF. et al. One-year echocardiographic, functional, and quality of life outcomes after ultrasound-facilitated catheter-based fibrinolysis for pulmonary embolism. Circ Cardiovasc Interv 2020; 13 (08) e009012
  • 41 Sadeghipour P, Jenab Y, Moosavi J. et al. Catheter-directed thrombolysis vs anticoagulation in patients with acute intermediate-high-risk pulmonary embolism: the CANARY randomized clinical trial. JAMA Cardiol 2022; 7 (12) 1189-1197
  • 42 Tu T, Toma C, Tapson VF. et al; FLARE Investigators. a prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study. JACC Cardiovasc Interv 2019; 12 (09) 859-869
  • 43 Toma C, Jaber WA, Weinberg MD. et al. Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism. EuroIntervention 2023; 18 (14) 1201-1212
  • 44 Sista AK, Horowitz JM, Tapson VF. et al; EXTRACT-PE Investigators. Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial. JACC Cardiovasc Interv 2021; 14 (03) 319-329
  • 45 Silver MJ, Gibson CM, Giri J. et al Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study. Circ Cardiovasc Interv 2023; 16 (10) e013406
  • 46 Carroll BJ, Shah RV, Murthy V. et al. Clinical features and outcomes in adults with cardiogenic shock supported by extracorporeal membrane oxygenation. Am J Cardiol 2015; 116 (10) 1624-1630
  • 47 Elbadawi A, Mentias A, Elgendy IY. et al. National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism. Vasc Med 2019; 24 (03) 230-233
  • 48 Provias T, Dudzinski DM, Jaff MR. et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract 2014; 42 (01) 31-37
  • 49 Barnes GD, Kabrhel C, Courtney DM. et al; National PERT Consortium Research Committee. Diversity in the pulmonary embolism response team model: an organizational survey of the national PERT consortium members. Chest 2016; 150 (06) 1414-1417
  • 50 Rivera-Lebron B, McDaniel M, Ahrar K. et al; PERT Consortium. Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT consortium. Clin Appl Thromb Hemost 2019; 25: 10 76029619853037
  • 51 Rosovsky R, Zhao K, Sista A, Rivera-Lebron B, Kabrhel C. Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions. Res Pract Thromb Haemost 2019; 3 (03) 315-330
  • 52 Rosovsky R, Chang Y, Rosenfield K. et al. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis 2019; 47 (01) 31-40
  • 53 Hobohm L, Farmakis IT, Keller K. et al. Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis. Clin Res Cardiol 2023; 112 (10) 1351-1361
  • 54 Tchantchaleishvili V, Hallinan W, Massey HT. Call for organized statewide networks for management of acute myocardial infarction-related cardiogenic shock. JAMA Surg 2015; 150 (11) 1025-1026
  • 55 Dalia AA, Ortoleva J, Fiedler A, Villavicencio M, Shelton K, Cudemus GD. Extracorporeal membrane oxygenation is a team sport: institutional survival benefits of a formalized ECMO team. J Cardiothorac Vasc Anesth 2019; 33 (04) 902-907
  • 56 Eckman PM, Katz JN, El Banayosy A, Bohula EA, Sun B, van Diepen S. Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock: an introduction for the busy clinician. Circulation 2019; 140 (24) 2019-2037
  • 57 Banfi C, Pozzi M, Brunner ME. et al. Veno-arterial extracorporeal membrane oxygenation: an overview of different cannulation techniques. J Thorac Dis 2016; 8 (09) E875-E885
  • 58 Zhao S, Friedman O. Management of right ventricular failure in pulmonary embolism. Crit Care Clin 2020; 36 (03) 505-515
  • 59 Nishimoto Y, Ohbe H, Matsui H. et al. Effectiveness of systemic thrombolysis on clinical outcomes in high-risk pulmonary embolism patients with venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study. J Intensive Care 2023; 11 (01) 4
  • 60 Chopard R, Nielsen P, Ius F. et al. Optimal reperfusion strategy in acute high-risk pulmonary embolism requiring extracorporeal membrane oxygenation support: a systematic review and meta-analysis. Eur Respir J 2022; 60 (05) 2102977
  • 61 Levy JH, Staudinger T, Steiner ME. How to manage anticoagulation during extracorporeal membrane oxygenation. Intensive Care Med 2022; 48 (08) 1076-1079
  • 62 Karami M, Mandigers L, Miranda DDR. et al; DUTCH ECLS Study Group. Survival of patients with acute pulmonary embolism treated with venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care 2021; 64: 245-254
  • 63 Corsi F, Lebreton G, Bréchot N. et al. Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation. Crit Care 2017; 21 (01) 76
  • 64 Al-Bawardy R, Rosenfield K, Borges J. et al. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a case series and review of the literature. Perfusion 2019; 34 (01) 22-28
  • 65 Dolmatova EV, Moazzami K, Cocke TP. et al. Extracorporeal membrane oxygenation in massive pulmonary embolism. Heart Lung 2017; 46 (02) 106-109
  • 66 George B, Parazino M, Omar HR. et al. A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support. Resuscitation 2018; 122: 1-5
  • 67 Ghoreishi M, DiChiacchio L, Pasrija C. et al. Predictors of recovery in patients supported with venoarterial extracorporeal membrane oxygenation for acute massive pulmonary embolism. Ann Thorac Surg 2020; 110 (01) 70-75
  • 68 Giraud R, Laurencet M, Assouline B, De Charrière A, Banfi C, Bendjelid K. Can VA-ECMO be used as an adequate treatment in massive pulmonary embolism?. J Clin Med 2021; 10 (15) 3376
  • 69 Ius F, Hoeper MM, Fegbeutel C. et al. Extracorporeal membrane oxygenation and surgical embolectomy for high-risk pulmonary embolism. Eur Respir J 2019; 53 (04) 1801773
  • 70 Kjaergaard B, Kristensen JH, Sindby JE, de Neergaard S, Rasmussen BS. Extracorporeal membrane oxygenation in life-threatening massive pulmonary embolism. Perfusion 2019; 34 (06) 467-474
  • 71 Ltaief Z, Lupieri E, Bonnemain J, Ben-Hamouda N, Rancati V, Kobbe SS. et al. Venoarterial extracorporeal membrane oxygenation in high-risk pulmonary embolism: a case series and literature review. RCM 2022;23(06):
  • 72 Luna-López R, Sousa-Casasnovas I, García-Carreño J, Devesa-Cordero C, Fernández-Avilés F, Martínez-Sellés M. Use of extracorporeal membrane oxygenator in massive pulmonary embolism. Rev Esp Cardiol (Engl Ed) 2019; 72 (09) 793-794
  • 73 Maggio P, Hemmila M, Haft J, Bartlett R. Extracorporeal life support for massive pulmonary embolism. J Trauma 2007; 62 (03) 570-576
  • 74 Maj G, Melisurgo G, De Bonis M, Pappalardo F. ECLS management in pulmonary embolism with cardiac arrest: which strategy is better?. Resuscitation 2014; 85 (10) e175-e176
  • 75 Malekan R, Saunders PC, Yu CJ. et al. Peripheral extracorporeal membrane oxygenation: comprehensive therapy for high-risk massive pulmonary embolism. Ann Thorac Surg 2012; 94 (01) 104-108
  • 76 Meneveau N, Guillon B, Planquette B. et al. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J 2018; 39 (47) 4196-4204
  • 77 Miyazaki K, Hikone M, Kuwahara Y, Ishida T, Sugiyama K, Hamabe Y. Extracorporeal CPR for massive pulmonary embolism in a “hybrid 2136 emergency department.”. Am J Emerg Med 2019; 37 (12) 2132-2135
  • 78 Moon D, Lee SN, Yoo KD, Jo MS. Extracorporeal membrane oxygenation improved survival in patients with massive pulmonary embolism. Ann Saudi Med 2018; 38 (03) 174-180
  • 79 Munakata R, Yamamoto T, Hosokawa Y. et al. Massive pulmonary embolism requiring extracorporeal life support treated with catheter-based interventions. Int Heart J 2012; 53 (06) 370-374
  • 80 Oh YN, Oh DK, Koh Y. et al. Use of extracorporeal membrane oxygenation in patients with acute high-risk pulmonary embolism: a case series with literature review. Acute Crit Care 2019; 34 (02) 148-154
  • 81 Pasrija C, Kronfli A, George P. et al. Utilization of veno-arterial extracorporeal membrane oxygenation for massive pulmonary embolism. Ann Thorac Surg 2018; 105 (02) 498-504
  • 82 Swol J, Buchwald D, Strauch J, Schildhauer TA. Extracorporeal life support (ECLS) for cardiopulmonary resuscitation (CPR) with pulmonary embolism in surgical patients: a case series. Perfusion 2016; 31 (01) 54-59
  • 83 Assouline B, Assouline-Reinmann M, Giraud R. et al. Management of high-risk pulmonary embolism: what is the place of extracorporeal membrane oxygenation?. J Clin Med 2022; 11 (16) 4734
  • 84 Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 2012; 125 (05) 465-470
  • 85 Keller K, Hobohm L, Ebner M. et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 2020; 41 (04) 522-529
  • 86 Hobohm L, Sagoschen I, Habertheuer A. et al. Clinical use and outcome of extracorporeal membrane oxygenation in patients with pulmonary embolism. Resuscitation 2022; 170: 285-292
  • 87 QiMin W, LiangWan C, DaoZhong C. et al. Clinical outcomes of acute pulmonary embolectomy as the first-line treatment for massive and submassive pulmonary embolism: a single-centre study in China. J Cardiothorac Surg 2020; 15 (01) 321
  • 88 Kadner A, Schmidli J, Schönhoff F. et al. Excellent outcome after surgical treatment of massive pulmonary embolism in critically ill patients. J Thorac Cardiovasc Surg 2008; 136 (02) 448-451
  • 89 Fukuda I, Taniguchi S, Fukui K, Minakawa M, Daitoku K, Suzuki Y. Improved outcome of surgical pulmonary embolectomy by aggressive intervention for critically ill patients. Ann Thorac Surg 2011; 91 (03) 728-732
  • 90 Neely RC, Byrne JG, Gosev I. et al. Surgical embolectomy for acute massive and submassive pulmonary embolism in a series of 115 patients. Ann Thorac Surg 2015; 100 (04) 1245-1251 , discussion 1251–1252
  • 91 Kucher N, Ouda A, Voci D. et al. Percutaneous large-bore aspiration embolectomy with veno-arterial extracorporal membrane oxygenation support or standby in patients with high-risk pulmonary embolism and contraindications to thrombolysis: a preliminary single centre experience. Eur Heart J Acute Cardiovasc Care 2023; 12 (04) 232-236
  • 92 Guglin M, Zucker MJ, Bazan VM. et al. Venoarterial ECMO for adults: JACC Scientific Expert Panel. J Am Coll Cardiol 2019; 73 (06) 698-716
  • 93 Cecconi M, De Backer D, Antonelli M. et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014; 40 (12) 1795-1815
  • 94 Konstantinides SV, Meyer G, Becattini C. et al. ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41 (04) 543-603
  • 95 Kaso ER, Pan JA, Salerno M. et al. Venoarterial extracorporeal membrane oxygenation for acute massive pulmonary embolism: a meta-analysis and call to action. J Cardiovasc Transl Res 2022; 15 (02) 258-267
  • 96 Goldberg JB, Spevack DM, Ahsan S. et al. Survival and right ventricular function after surgical management of acute pulmonary embolism. J Am Coll Cardiol 2020; 76 (08) 903-911
  • 97 Pasrija C, Shah A, George P. et al. Triage and optimization: a new paradigm in the treatment of massive pulmonary embolism. J Thorac Cardiovasc Surg 2018; 156 (02) 672-681
  • 98 Kabrhel C, Rosovsky R, Channick R. et al. A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest 2016; 150 (02) 384-393
  • 99 Nolan JP, Sandroni C, Böttiger BW. et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care. Intensive Care Med 2021; 47 (04) 369-421
  • 100 Ouweneel DM, Engstrom AE, Sjauw KD. et al. Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock. Lessons learned from the IMPRESS in STEMI trial. Int J Cardiol 2016; 202: 894-896